Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jeffrey Olson

Concepts (315)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vitreous Body
14
2020
92
3.850
 Why?
Ophthalmologic Surgical Procedures
5
2017
58
2.800
 Why?
Angiogenesis Inhibitors
10
2020
207
2.320
 Why?
Retina
11
2016
227
2.250
 Why?
Glaucoma
4
2017
140
2.210
 Why?
Alloys
4
2013
29
2.080
 Why?
Eye Foreign Bodies
5
2016
23
2.070
 Why?
Retinal Detachment
6
2019
49
1.990
 Why?
Diabetic Retinopathy
6
2019
144
1.960
 Why?
Vitrectomy
7
2019
58
1.930
 Why?
Glaucoma Drainage Implants
3
2016
34
1.850
 Why?
Retinal Diseases
5
2017
62
1.660
 Why?
Intraocular Pressure
7
2017
220
1.610
 Why?
Nanopores
2
2020
6
1.570
 Why?
Membranes, Artificial
2
2020
74
1.500
 Why?
Nanotechnology
2
2020
120
1.400
 Why?
Suction
3
2015
34
1.320
 Why?
Intravitreal Injections
6
2020
37
1.290
 Why?
Choroidal Neovascularization
4
2011
44
1.260
 Why?
Sutures
3
2015
47
1.260
 Why?
Anterior Eye Segment
2
2017
10
1.240
 Why?
Swine
10
2017
674
1.220
 Why?
Suture Techniques
3
2015
126
1.180
 Why?
Equipment Design
6
2017
526
1.150
 Why?
Lens Implantation, Intraocular
2
2015
42
1.140
 Why?
Macular Edema
3
2020
22
1.040
 Why?
Vitreoretinopathy, Proliferative
2
2019
11
0.970
 Why?
Vascular Endothelial Growth Factor A
6
2020
491
0.920
 Why?
Durapatite
1
2020
40
0.910
 Why?
Cytomegalovirus Retinitis
2
2013
16
0.900
 Why?
Retinal Vessels
2
2015
61
0.900
 Why?
Complement System Proteins
2
2020
223
0.900
 Why?
Isoxazoles
2
2013
51
0.880
 Why?
Scleral Buckling
3
2012
14
0.870
 Why?
Eye Injuries, Penetrating
3
2016
18
0.870
 Why?
Endophthalmitis
2
2017
28
0.870
 Why?
Stents
2
2013
384
0.840
 Why?
Disease Models, Animal
8
2020
3738
0.830
 Why?
Immunosuppressive Agents
3
2013
864
0.820
 Why?
Fluorocarbons
2
2012
68
0.800
 Why?
Antibodies, Monoclonal
5
2011
1272
0.790
 Why?
Anterior Chamber
1
2017
19
0.740
 Why?
Transducers
1
2017
37
0.720
 Why?
Strabismus
1
2017
23
0.720
 Why?
Glucocorticoids
2
2020
513
0.720
 Why?
Sclera
2
2015
35
0.700
 Why?
Trabeculectomy
1
2017
49
0.690
 Why?
Filtering Surgery
1
2016
22
0.690
 Why?
Ophthalmology
2
2013
37
0.690
 Why?
Surgical Instruments
2
2013
46
0.680
 Why?
Laser Therapy
1
2017
88
0.670
 Why?
Fovea Centralis
2
2006
10
0.670
 Why?
Ocular Hypertension
1
2016
44
0.670
 Why?
Retinal Perforations
2
2005
9
0.660
 Why?
Drug Resistance, Multiple, Viral
2
2013
13
0.650
 Why?
Lenses, Intraocular
1
2015
19
0.650
 Why?
Lasers
1
2015
113
0.630
 Why?
Tomography, Optical Coherence
7
2015
117
0.620
 Why?
Device Removal
1
2016
119
0.610
 Why?
Monitoring, Physiologic
1
2017
274
0.610
 Why?
Ischemia
2
2017
306
0.600
 Why?
Macular Degeneration
6
2015
79
0.590
 Why?
Prostheses and Implants
1
2016
154
0.590
 Why?
Fluorescein Angiography
9
2012
102
0.580
 Why?
Antiviral Agents
2
2013
601
0.580
 Why?
Retinal Degeneration
2
2015
26
0.560
 Why?
Rabbits
3
2020
730
0.560
 Why?
Artificial Lens Implant Migration
1
2013
3
0.550
 Why?
Models, Cardiovascular
1
2015
178
0.550
 Why?
Choroid
3
2015
47
0.550
 Why?
Viscosupplements
1
2012
10
0.540
 Why?
Gravitation
1
2012
21
0.540
 Why?
Silicon
1
2012
16
0.530
 Why?
Animals
18
2020
34264
0.530
 Why?
Pupil Disorders
1
2012
6
0.530
 Why?
Eye Enucleation
1
2012
11
0.530
 Why?
Iris
1
2012
19
0.520
 Why?
Viremia
1
2013
111
0.520
 Why?
Silicone Oils
1
2012
43
0.520
 Why?
Cataract Extraction
1
2013
49
0.520
 Why?
Silicone Elastomers
1
2012
8
0.520
 Why?
Fluocinolone Acetonide
1
2012
12
0.510
 Why?
Uveitis, Posterior
1
2012
10
0.510
 Why?
Quantum Dots
1
2012
42
0.510
 Why?
Surgical Stapling
1
2012
8
0.510
 Why?
Prosthesis Implantation
1
2013
123
0.500
 Why?
Vitreous Hemorrhage
2
2015
7
0.500
 Why?
Electric Stimulation Therapy
1
2012
64
0.490
 Why?
Vascular Endothelial Growth Factors
1
2011
78
0.480
 Why?
Models, Biological
4
2015
1842
0.440
 Why?
Materials Testing
1
2012
326
0.440
 Why?
Cytomegalovirus
2
2013
141
0.440
 Why?
Oxygen
1
2015
844
0.440
 Why?
Humans
45
2020
104249
0.420
 Why?
Biocompatible Materials
1
2012
279
0.400
 Why?
Anti-Inflammatory Agents
1
2012
448
0.380
 Why?
Interleukin 1 Receptor Antagonist Protein
1
2009
281
0.370
 Why?
Electroretinography
5
2016
36
0.370
 Why?
von Hippel-Lindau Disease
1
2007
12
0.360
 Why?
Injections
5
2012
127
0.360
 Why?
Antibodies, Monoclonal, Humanized
6
2015
585
0.360
 Why?
Pigment Epithelium of Eye
2
2006
34
0.350
 Why?
Puerperal Disorders
1
2007
38
0.350
 Why?
Kidney Transplantation
2
2013
432
0.350
 Why?
Drug Implants
2
2020
68
0.350
 Why?
Uveal Diseases
1
2006
5
0.340
 Why?
Visual Acuity
7
2019
217
0.340
 Why?
Ocular Hypotension
1
2006
7
0.340
 Why?
Fusobacterium Infections
1
2006
6
0.340
 Why?
Epiretinal Membrane
1
2005
4
0.340
 Why?
Pharyngeal Diseases
1
2006
17
0.330
 Why?
Ciliary Body
1
2006
33
0.330
 Why?
Uveitis
1
2006
96
0.330
 Why?
Needles
2
2017
52
0.330
 Why?
Telangiectasis
1
2005
4
0.330
 Why?
Rats, Inbred BN
3
2011
67
0.320
 Why?
Injections, Intraocular
2
2015
10
0.300
 Why?
Polypropylenes
2
2015
16
0.300
 Why?
Middle Aged
17
2019
27633
0.280
 Why?
Female
24
2019
59707
0.270
 Why?
Laser Coagulation
3
2012
47
0.270
 Why?
Bevacizumab
6
2015
127
0.260
 Why?
Autoimmune Diseases
1
2006
422
0.260
 Why?
Retinal Vein Occlusion
2
2015
13
0.250
 Why?
Cell Count
2
2012
347
0.240
 Why?
Dialysis
1
2020
28
0.230
 Why?
Leukemia, Megakaryoblastic, Acute
1
2000
8
0.230
 Why?
Orbital Neoplasms
1
2000
24
0.230
 Why?
Adsorption
1
2020
157
0.220
 Why?
Rats
4
2012
6717
0.210
 Why?
Male
21
2019
58392
0.210
 Why?
Biomarkers
2
2020
3163
0.210
 Why?
Follow-Up Studies
5
2015
4685
0.210
 Why?
Wet Macular Degeneration
1
2019
23
0.210
 Why?
Geographic Atrophy
1
2019
26
0.200
 Why?
Time Factors
4
2017
7066
0.200
 Why?
Fluorescein-5-isothiocyanate
2
2009
33
0.200
 Why?
Eye Diseases, Hereditary
1
2018
14
0.200
 Why?
Miniaturization
2
2015
21
0.190
 Why?
Dextrans
2
2009
78
0.190
 Why?
Hypertension
1
2006
1110
0.190
 Why?
Glomerulonephritis, Membranoproliferative
1
1997
8
0.190
 Why?
Iris Diseases
1
2017
6
0.180
 Why?
Choroid Diseases
1
2017
10
0.180
 Why?
Dark Adaptation
2
2012
11
0.180
 Why?
Antimony
1
2016
3
0.180
 Why?
Infliximab
2
2007
81
0.170
 Why?
Enzyme-Linked Immunosorbent Assay
1
2019
915
0.170
 Why?
Down Syndrome
1
2000
252
0.170
 Why?
Polymers
1
2020
401
0.170
 Why?
Sclerostomy
1
2015
4
0.170
 Why?
Pressure
1
2017
257
0.170
 Why?
Aged, 80 and over
6
2019
6518
0.170
 Why?
Treatment Outcome
9
2016
8608
0.170
 Why?
Gyrate Atrophy
1
2015
2
0.160
 Why?
Foreign-Body Migration
1
2016
33
0.160
 Why?
Adult
10
2019
30359
0.160
 Why?
Vitreoretinal Surgery
1
2015
4
0.160
 Why?
Vitreous Detachment
1
2015
4
0.160
 Why?
Diagnostic Techniques, Ophthalmological
1
2015
31
0.160
 Why?
Partial Pressure
1
2015
32
0.160
 Why?
Hemoglobin SC Disease
1
2015
13
0.160
 Why?
Eye Infections, Bacterial
1
2015
29
0.160
 Why?
Dose-Response Relationship, Drug
3
2014
2242
0.160
 Why?
Feedback
1
2015
129
0.160
 Why?
Equipment Failure Analysis
1
2015
132
0.160
 Why?
Stress, Mechanical
1
2017
450
0.160
 Why?
Diabetes Mellitus, Type 2
2
2012
1796
0.150
 Why?
Biopsy, Needle
1
2015
195
0.150
 Why?
Health Knowledge, Attitudes, Practice
2
2014
1148
0.150
 Why?
Prosthesis Failure
1
2016
129
0.150
 Why?
Oculomotor Muscles
1
2014
38
0.150
 Why?
Aged
9
2019
18934
0.150
 Why?
International Normalized Ratio
1
2014
72
0.150
 Why?
Retinal Artery Occlusion
1
2013
6
0.140
 Why?
Exchange Transfusion, Whole Blood
1
2013
17
0.140
 Why?
Protein Binding
1
2020
2098
0.140
 Why?
Research Design
1
2019
834
0.140
 Why?
Tendons
1
2014
100
0.140
 Why?
Postoperative Care
1
2015
285
0.140
 Why?
Erythrocyte Transfusion
1
2015
178
0.140
 Why?
Specific Gravity
1
2012
14
0.140
 Why?
Transducers, Pressure
1
2012
14
0.140
 Why?
Adaptation, Ocular
1
2012
7
0.130
 Why?
Metabolomics
1
2018
497
0.130
 Why?
Minerals
1
2012
33
0.130
 Why?
Rats, Mutant Strains
1
2012
24
0.130
 Why?
Pupil
1
2012
12
0.130
 Why?
In Vitro Techniques
1
2015
1302
0.130
 Why?
Warfarin
1
2014
162
0.130
 Why?
Viscosity
1
2012
95
0.130
 Why?
Corneal Endothelial Cell Loss
1
2012
2
0.130
 Why?
Recombinant Fusion Proteins
3
2013
692
0.130
 Why?
Endothelium, Corneal
1
2012
9
0.130
 Why?
Dementia
1
2014
170
0.130
 Why?
Adolescent
4
2019
17541
0.130
 Why?
Retinal Neovascularization
1
2012
23
0.130
 Why?
Acetates
1
2012
104
0.130
 Why?
Drug Combinations
1
2012
272
0.130
 Why?
Microsurgery
1
2012
46
0.130
 Why?
Retinal Ganglion Cells
1
2012
68
0.120
 Why?
Swine, Miniature
1
2012
80
0.120
 Why?
Retrospective Studies
8
2015
10064
0.120
 Why?
Electrodes, Implanted
1
2012
99
0.120
 Why?
Sodium Chloride
1
2012
160
0.120
 Why?
Bruch Membrane
1
2011
6
0.120
 Why?
Gold
1
2012
97
0.120
 Why?
Polyglycolic Acid
1
2011
42
0.120
 Why?
Tumor Necrosis Factor-alpha
2
2007
1194
0.120
 Why?
Anemia, Sickle Cell
1
2013
170
0.120
 Why?
Registries
1
2019
1661
0.120
 Why?
Drug Compounding
1
2011
88
0.120
 Why?
Delayed-Action Preparations
1
2011
150
0.110
 Why?
Administration, Oral
1
2013
812
0.110
 Why?
Dissection
1
2011
53
0.110
 Why?
Atrial Fibrillation
1
2014
331
0.110
 Why?
Computer Simulation
1
2015
902
0.110
 Why?
Models, Animal
1
2012
392
0.100
 Why?
Lactic Acid
1
2011
293
0.100
 Why?
Bacteria
1
2015
648
0.100
 Why?
Cell Survival
1
2012
1106
0.100
 Why?
Scotoma
1
2008
5
0.100
 Why?
Proliferating Cell Nuclear Antigen
1
2007
58
0.090
 Why?
Optic Neuropathy, Ischemic
1
2007
30
0.090
 Why?
Papilledema
1
2007
33
0.090
 Why?
Pilot Projects
1
2012
1323
0.090
 Why?
Visual Fields
3
2007
79
0.090
 Why?
Retinitis Pigmentosa
1
2006
14
0.090
 Why?
Severity of Illness Index
2
2014
2653
0.090
 Why?
Triamcinolone Acetonide
1
2006
21
0.090
 Why?
Myopia
1
2006
19
0.090
 Why?
Glycogen Storage Disease Type IIb
1
2006
23
0.090
 Why?
Fusobacterium necrophorum
1
2006
1
0.090
 Why?
RNA, Catalytic
1
2007
194
0.080
 Why?
Indocyanine Green
1
2005
29
0.080
 Why?
Vision, Low
3
2013
14
0.080
 Why?
Polyethylene Glycols
1
2011
543
0.080
 Why?
Young Adult
2
2019
10261
0.080
 Why?
Coloring Agents
1
2005
79
0.080
 Why?
Eye Injuries
1
2006
46
0.080
 Why?
Staining and Labeling
1
2005
170
0.080
 Why?
Syndrome
1
2006
318
0.080
 Why?
Infusions, Intravenous
1
2006
440
0.080
 Why?
Cataract
1
2006
133
0.080
 Why?
Multivariate Analysis
2
2019
1587
0.060
 Why?
Ranibizumab
2
2013
17
0.060
 Why?
Diagnosis, Differential
1
2007
1433
0.060
 Why?
Blindness
2
2013
37
0.060
 Why?
Receptors, Vascular Endothelial Growth Factor
2
2013
103
0.060
 Why?
Exophthalmos
1
2000
13
0.060
 Why?
Keratitis
1
2000
17
0.060
 Why?
Postoperative Complications
1
2012
2086
0.060
 Why?
Chronic Disease
1
2006
1686
0.050
 Why?
Immunophenotyping
1
2000
307
0.050
 Why?
Xanthine
1
2018
10
0.050
 Why?
Tomography, X-Ray Computed
2
2016
2264
0.050
 Why?
Child
2
2015
15648
0.050
 Why?
Electrooculography
1
1997
28
0.050
 Why?
Visual Field Tests
1
1997
14
0.050
 Why?
Color Vision Defects
1
1997
7
0.050
 Why?
Fundus Oculi
1
1997
42
0.050
 Why?
Combined Modality Therapy
2
2013
1206
0.050
 Why?
Purines
1
2018
149
0.040
 Why?
Cohort Studies
2
2019
4560
0.040
 Why?
Photic Stimulation
1
1997
233
0.040
 Why?
Vision Disorders
1
1997
110
0.040
 Why?
Odds Ratio
1
2019
1033
0.040
 Why?
Pregnancy
1
2007
4800
0.040
 Why?
Myopia, Degenerative
1
2015
2
0.040
 Why?
Endotamponade
1
2015
3
0.040
 Why?
Microbiological Techniques
1
2015
39
0.040
 Why?
Colony Count, Microbial
1
2015
95
0.040
 Why?
Metabolome
1
2018
244
0.040
 Why?
Tenon Capsule
1
2014
3
0.040
 Why?
Tissue Adhesions
1
2015
28
0.040
 Why?
Atrophy
1
2015
133
0.040
 Why?
Photography
1
2015
83
0.040
 Why?
Conjunctiva
1
2014
52
0.040
 Why?
Disease Progression
2
2015
2341
0.040
 Why?
Biometry
1
2014
70
0.040
 Why?
Mass Spectrometry
1
2018
755
0.040
 Why?
Glucose
1
2018
819
0.030
 Why?
Risk Factors
2
2019
8467
0.030
 Why?
Fatty Acids, Omega-3
1
2014
123
0.030
 Why?
Retreatment
1
2012
63
0.030
 Why?
Risk Assessment
2
2014
2934
0.030
 Why?
Kaplan-Meier Estimate
1
2014
864
0.030
 Why?
Oxidative Stress
1
2018
1179
0.030
 Why?
Global Health
1
2014
325
0.030
 Why?
Proportional Hazards Models
1
2014
1072
0.030
 Why?
Phenotype
1
2019
2862
0.030
 Why?
Survival Analysis
1
2014
1406
0.030
 Why?
Health Care Costs
1
2014
392
0.030
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
385
0.030
 Why?
Clinical Trials, Phase II as Topic
1
2009
55
0.030
 Why?
Antioxidants
1
2014
576
0.030
 Why?
Clinical Trials, Phase I as Topic
1
2009
54
0.030
 Why?
Anticoagulants
1
2014
532
0.030
 Why?
Comorbidity
1
2014
1537
0.030
 Why?
Prospective Studies
2
2012
5605
0.030
 Why?
Colorado
1
2019
4483
0.020
 Why?
Antineoplastic Agents
1
2000
2033
0.020
 Why?
Retinal Artery
1
2007
13
0.020
 Why?
Cerebral Angiography
1
2007
80
0.020
 Why?
Infant
1
2000
7629
0.020
 Why?
Lysosome-Associated Membrane Glycoproteins
1
2006
22
0.020
 Why?
Frameshift Mutation
1
2006
30
0.020
 Why?
Lysosomal-Associated Membrane Protein 2
1
2006
30
0.020
 Why?
Anti-Bacterial Agents
1
2015
1243
0.020
 Why?
Prognosis
1
2014
3289
0.020
 Why?
Secondary Prevention
1
2007
245
0.020
 Why?
Adrenal Cortex Hormones
1
2008
497
0.020
 Why?
Double-Blind Method
1
2007
1609
0.020
 Why?
RNA, Messenger
1
2007
2914
0.010
 Why?
Aging
1
2008
1668
0.010
 Why?
Olson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (315) concept(s)
_
Co-Authors Expand Description
See all (24) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2021 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)